FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009133610> ?p ?o ?g. }

• W2009133610 abstract "Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DCDeregulation of the Cdk/Rb/E2F axis is a common feature among cancers. Several promising ATP-competitive Cdk inhibitors are undergoing clinical testing as anticancer therapeutics. However a weakness of ATP-competitive Cdk inhibitors is that all kinases share a highly conserved ATP binding site, making it difficult to selectively inhibit cell cycle Cdks. Further, there is significant functional redundancy among cell cycle Cdks, so the ideal Cdk inhibitor would block the activity of multiple cell cycle Cdks while not affecting other kinases. Nature utilizes several modes of regulation that are specific to the Cdks that involve (1) the inhibitory proteins p21, p27, and p57, (2) inhibitory phosphorylation on a tyrosine residue near the ATP binding pocket, (3) activating phosphorylation on the “T-loop” site, and (4) binding of an activating Cyclin subunit. Usurping one of these natural Cdk-specific control mechanisms may be the best hope for developing potent and selective anticancer Cdk inhibitors.Comparison of the crystal structures of Cyclin A/Cdk2/p27 and Cyclin A/Cdk2 complexes indicated that p27 binding causes a conformational change, which opens a pocket on the surface of Cdk2. We hypothesized that a small molecule that binds to this pocket would force Cdks to adopt an inactive conformation. In silico molecular docking was performed to identify compounds predicted to bind to this pocket. Multiple compounds identified in this screen inhibited the proliferation of breast cancer cells. Inhibition of proliferation correlated with a decrease in the soluble levels of Cdk1, Cdk2, and Cdk4, and an increase in these proteins in the insoluble fraction. Video microscopy of cells stably expressing a GFP-Cdk4 fusion protein showed aggregate formation over time in the presence of the Cdk inhibitors and that the aggregates dissipated after the drug was removed. Proliferation studies performed in parallel also indicated that the effects of the Cdk inhibitors were largely reversible within the first 24 hours.One of the compounds, NSC117024, preferentially inhibited the proliferation of BT549 breast cancer cells over nontransformed mammary epithelial cells. Inhibition of BT549 proliferation was observed at NSC117024 concentrations as low as 780 nM. Interestingly, suppression of cancer cell division by the compounds occurred as well or better in cells lacking p21 and p27. The compounds directly inhibited Cdk2 activity in kinase assays. Together the results suggest that the novel family of Cdk inhibitors mimic the actions of p21 and p27 and may preferentially inhibit the proliferation of a subset of breast cancer cells. Current efforts are directed toward optimizing NSC117024 antiproliferative activity, developing a biotinylated NSC117024 affinity probe to verify compound specificity, and identifying the genetic features of cancer cells that render them sensitive to NSC117024.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3881." @default.
• W2009133610 created "2016-06-24" @default.
• W2009133610 creator A5007022577 @default.
• W2009133610 creator A5014140014 @default.
• W2009133610 creator A5021962959 @default.
• W2009133610 creator A5037060910 @default.
• W2009133610 creator A5037116125 @default.
• W2009133610 creator A5078512022 @default.
• W2009133610 date "2010-04-15" @default.
• W2009133610 modified "2023-09-26" @default.
• W2009133610 title "Abstract 3881: A novel class of structure-based cyclin-dependent kinase inhibitors" @default.
• W2009133610 doi "https://doi.org/10.1158/1538-7445.am10-3881" @default.
• W2009133610 hasPublicationYear "2010" @default.
• W2009133610 type Work @default.
• W2009133610 sameAs 2009133610 @default.
• W2009133610 citedByCount "0" @default.
• W2009133610 crossrefType "proceedings-article" @default.
• W2009133610 hasAuthorship W2009133610A5007022577 @default.
• W2009133610 hasAuthorship W2009133610A5014140014 @default.
• W2009133610 hasAuthorship W2009133610A5021962959 @default.
• W2009133610 hasAuthorship W2009133610A5037060910 @default.
• W2009133610 hasAuthorship W2009133610A5037116125 @default.
• W2009133610 hasAuthorship W2009133610A5078512022 @default.
• W2009133610 hasConcept C11960822 @default.
• W2009133610 hasConcept C124320809 @default.
• W2009133610 hasConcept C1491633281 @default.
• W2009133610 hasConcept C16438837 @default.
• W2009133610 hasConcept C184235292 @default.
• W2009133610 hasConcept C185592680 @default.
• W2009133610 hasConcept C2778298596 @default.
• W2009133610 hasConcept C29537977 @default.
• W2009133610 hasConcept C55493867 @default.
• W2009133610 hasConcept C82495950 @default.
• W2009133610 hasConcept C84815855 @default.
• W2009133610 hasConcept C86803240 @default.
• W2009133610 hasConcept C95444343 @default.
• W2009133610 hasConcept C97029542 @default.
• W2009133610 hasConceptScore W2009133610C11960822 @default.
• W2009133610 hasConceptScore W2009133610C124320809 @default.
• W2009133610 hasConceptScore W2009133610C1491633281 @default.
• W2009133610 hasConceptScore W2009133610C16438837 @default.
• W2009133610 hasConceptScore W2009133610C184235292 @default.
• W2009133610 hasConceptScore W2009133610C185592680 @default.
• W2009133610 hasConceptScore W2009133610C2778298596 @default.
• W2009133610 hasConceptScore W2009133610C29537977 @default.
• W2009133610 hasConceptScore W2009133610C55493867 @default.
• W2009133610 hasConceptScore W2009133610C82495950 @default.
• W2009133610 hasConceptScore W2009133610C84815855 @default.
• W2009133610 hasConceptScore W2009133610C86803240 @default.
• W2009133610 hasConceptScore W2009133610C95444343 @default.
• W2009133610 hasConceptScore W2009133610C97029542 @default.
• W2009133610 hasLocation W20091336101 @default.
• W2009133610 hasOpenAccess W2009133610 @default.
• W2009133610 hasPrimaryLocation W20091336101 @default.
• W2009133610 hasRelatedWork W1705598372 @default.
• W2009133610 hasRelatedWork W1851389060 @default.
• W2009133610 hasRelatedWork W2047628330 @default.
• W2009133610 hasRelatedWork W2081486992 @default.
• W2009133610 hasRelatedWork W2089167153 @default.
• W2009133610 hasRelatedWork W2106158149 @default.
• W2009133610 hasRelatedWork W2298805882 @default.
• W2009133610 hasRelatedWork W2326310410 @default.
• W2009133610 hasRelatedWork W2600476284 @default.
• W2009133610 hasRelatedWork W2955403780 @default.
• W2009133610 hasRelatedWork W2994492843 @default.
• W2009133610 hasRelatedWork W3013978388 @default.
• W2009133610 hasRelatedWork W3024561493 @default.
• W2009133610 hasRelatedWork W3111821491 @default.
• W2009133610 hasRelatedWork W3118326006 @default.
• W2009133610 hasRelatedWork W3181601495 @default.
• W2009133610 hasRelatedWork W3210628792 @default.
• W2009133610 hasRelatedWork W46657795 @default.
• W2009133610 hasRelatedWork W2258497331 @default.
• W2009133610 hasRelatedWork W3082537875 @default.
• W2009133610 isParatext "false" @default.
• W2009133610 isRetracted "false" @default.
• W2009133610 magId "2009133610" @default.
• W2009133610 workType "article" @default.